In Spain, the consumption of lipid-lowering drugs increased by 442% between 2000 and 2012 from 18.9 defined daily doses in 2000 to 102.6 defined daily doses in 2012 and statins accounted for 89.3% of lipid-lowering drug use in 2012 atorvastatin and simvastatin accounted for 78.2% of this percentage.
El consumo de hipolipemiantes en España se ha incrementado entre 2000 y 2012 un 442% de 18,9 dosis diarias definidas en 2000 a 102,6 en 2012 y las estatinas representaron el 89,3% del uso de hipolipemiantes en 2012 atorvastatina y simvastatina fueron el 78,2% de ese consumo.